US 10166255
Intracellular genomic transplant and methods of therapy
granted A61KA61K2239/38A61K40/11
Quick answer
US patent 10166255 (Intracellular genomic transplant and methods of therapy) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Dec 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Jan 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 31
- CPC classes
- A61K, A61K2239/38, A61K40/11, A61K40/22, A61K40/32